These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16702881)

  • 1. The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease.
    Jack RM; Gordon C; Scott CR; Kishnani PS; Bali D
    Genet Med; 2006 May; 8(5):307-12. PubMed ID: 16702881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease.
    Zhang H; Kallwass H; Young SP; Carr C; Dai J; Kishnani PS; Millington DS; Keutzer J; Chen YT; Bali D
    Genet Med; 2006 May; 8(5):302-6. PubMed ID: 16702880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.
    Kallwass H; Carr C; Gerrein J; Titlow M; Pomponio R; Bali D; Dai J; Kishnani P; Skrinar A; Corzo D; Keutzer J
    Mol Genet Metab; 2007 Apr; 90(4):449-52. PubMed ID: 17270480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates.
    van Diggelen OP; Oemardien LF; van der Beek NA; Kroos MA; Wind HK; Voznyi YV; Burke D; Jackson M; Winchester BG; Reuser AJ
    J Inherit Metab Dis; 2009 Jun; 32(3):416-23. PubMed ID: 19387865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease.
    Umapathysivam K; Hopwood JJ; Meikle PJ
    Clin Chem; 2001 Aug; 47(8):1378-83. PubMed ID: 11468225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved assay for differential diagnosis between Pompe disease and acid α-glucosidase pseudodeficiency on dried blood spots.
    Shigeto S; Katafuchi T; Okada Y; Nakamura K; Endo F; Okuyama T; Takeuchi H; Kroos MA; Verheijen FW; Reuser AJ; Okumiya T
    Mol Genet Metab; 2011 May; 103(1):12-7. PubMed ID: 21320792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening.
    Lukacs Z; Nieves Cobos P; Mengel E; Hartung R; Beck M; Deschauer M; Keil A; Santer R
    J Inherit Metab Dis; 2010 Feb; 33(1):43-50. PubMed ID: 20033296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new diagnostic assay for glycogen storage disease type II in mixed leukocytes.
    Okumiya T; Keulemans JL; Kroos MA; Van der Beek NM; Boer MA; Takeuchi H; Van Diggelen OP; Reuser AJ
    Mol Genet Metab; 2006 May; 88(1):22-8. PubMed ID: 16359900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for Pompe disease in Japan.
    Oda E; Tanaka T; Migita O; Kosuga M; Fukushi M; Okumiya T; Osawa M; Okuyama T
    Mol Genet Metab; 2011 Dec; 104(4):560-5. PubMed ID: 21963784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program.
    Chien YH; Chiang SC; Zhang XK; Keutzer J; Lee NC; Huang AC; Chen CA; Wu MH; Huang PH; Tsai FJ; Chen YT; Hwu WL
    Pediatrics; 2008 Jul; 122(1):e39-45. PubMed ID: 18519449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy.
    Parenti G; Fecarotta S; la Marca G; Rossi B; Ascione S; Donati MA; Morandi LO; Ravaglia S; Pichiecchio A; Ombrone D; Sacchini M; Pasanisi MB; De Filippi P; Danesino C; Della Casa R; Romano A; Mollica C; Rosa M; Agovino T; Nusco E; Porto C; Andria G
    Mol Ther; 2014 Nov; 22(11):2004-12. PubMed ID: 25052852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset form of Pompe disease.
    Mattosova S; Hlavata A; Spalek P; Kotysova L; Macekova D; Chandoga J
    Bratisl Lek Listy; 2015; 116(8):502-5. PubMed ID: 26350092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease.
    Wang Z; Okamoto P; Keutzer J
    Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic and biochemical studies point to AAGR-1 as the ortholog of human acid alpha-glucosidase in Caenorhabditis elegans.
    Sikora J; Urinovská J; Majer F; Poupetová H; Hlavatá J; Kostrouchová M; Ledvinová J; Hrebícek M
    Mol Cell Biochem; 2010 Aug; 341(1-2):51-63. PubMed ID: 20349118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.
    Van den Hout JM; Kamphoven JH; Winkel LP; Arts WF; De Klerk JB; Loonen MC; Vulto AG; Cromme-Dijkhuis A; Weisglas-Kuperus N; Hop W; Van Hirtum H; Van Diggelen OP; Boer M; Kroos MA; Van Doorn PA; Van der Voort E; Sibbles B; Van Corven EJ; Brakenhoff JP; Van Hove J; Smeitink JA; de Jong G; Reuser AJ; Van der Ploeg AT
    Pediatrics; 2004 May; 113(5):e448-57. PubMed ID: 15121988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the alpha-glucosidase activity of lymphocytes and granulocytes of human peripheral blood].
    Preobrazhenskaia ME; Minakova AL
    Vopr Med Khim; 1984; 30(1):77-82. PubMed ID: 6369775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Assessment of In Vitro Screening of α-Glucosidase Inhibitors from Plants with Acarbose as a Reference Standard.
    Miller N; Joubert E
    Planta Med; 2022 Oct; 88(12):1078-1091. PubMed ID: 34662924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-glucosidase activity in human leucocytes: choice of lymphocytes for the diagnosis of Pompe's disease and the carrier state.
    Taniguchi N; Kato E; Yoshida H; Iwaki S; Ohki T; Koizumi S
    Clin Chim Acta; 1978 Oct; 89(2):293-9. PubMed ID: 361294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic diagnosis of Pompe disease: lessons from 28 years of experience.
    Niño MY; Wijgerde M; de Faria DOS; Hoogeveen-Westerveld M; Bergsma AJ; Broeders M; van der Beek NAME; van den Hout HJM; van der Ploeg AT; Verheijen FW; Pijnappel WWMP
    Eur J Hum Genet; 2021 Mar; 29(3):434-446. PubMed ID: 33162552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory.
    Goldstein JL; Young SP; Changela M; Dickerson GH; Zhang H; Dai J; Peterson D; Millington DS; Kishnani PS; Bali DS
    Muscle Nerve; 2009 Jul; 40(1):32-6. PubMed ID: 19533645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.